New Key Statistics Module, Z-Score and F-Score
OTCPK:KSPHF Key Ratios
| Market Cap $ M | 1,117.73 |
| Enterprise Value $ M | 819.83 |
| P/E(ttm) | 14.00 |
| PE Ratio without NRI | 39.43 |
| Forward PE Ratio | 14.13 |
| Price/Book | 0.76 |
| Price/Sales | 2.17 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | 0.87 |
| Revenue (TTM) $ M | 516.00 |
| EPS (TTM) $ | 1.78 |
| Beneish M-Score | -1.98 |
| 10-y EBITDA Growth Rate % | 3.50 |
| 5-y EBITDA Growth Rate % | 21.50 |
| y-y EBITDA Growth Rate % | 7.10 |
| EV-to-EBIT | 7.78 |
| EV-to-EBITDA | 7.78 |
| PEG | 1.83 |
| Shares Outstanding M | 44.21 |
| Net Margin (%) | 15.50 |
| Operating Margin % | 5.87 |
| Pre-tax Margin (%) | 20.17 |
| Quick Ratio | 4.43 |
| Current Ratio | 5.92 |
| ROA % (ttm) | 5.14 |
| ROE % (ttm) | 5.96 |
| ROIC % (ttm) | 1.94 |
| Dividend Yield % | 2.29 |
| Altman Z-Score | 4.06 |
KSPHF Number of Guru Trades
KSPHF Volume of Guru Trades
Gurus Latest Trades with OTCPK:KSPHF
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
OTCPK:KSPHF is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Kissei Pharmaceutical Co Ltd Insider Transactions
No Available Data
News about OTCPK:KSPHF
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers